Efficacy and safety of substitution of bleomycin by low dose nivolumba in ABVD (Doxorubicin + Bleomycin + Vinblastine + Dacarbazine) backbone chemotherapy in newly diagnosed advanced-stage pediatric Hodgkin Lymphoma: A phase II/III, multicentric, open-label, randomized controlled trial 2026 · AIIMSJ · checked 42 minutes ago

Efficacy and safety of substitution of bleomycin by low dose nivolumba in ABVD (Doxorubicin + Bleomycin + Vinblastine + Dacarbazine) backbone chemotherapy in newly diagnosed advanced-stage pediatric Hodgkin Lymphoma: A phase II/III, multicentric, open-label, randomized controlled trial 2026 — Admit card & exam dates

1 notice from the recruiter: admit card, exam dates and document-verification calls. Every link opens the official document.

We never fill forms or hold logins — downloads happen on the recruiter's own site.